Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
20 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects diagnosed with NASH before randomization
Subjects who conducts diet or exercise therapy at the beginning of run in period.
Subjects who has given full and adequate information of the protocol and with written informed consent
Subjects with hepatic failure or previously diagnosed with hepatic cirrhosis
Subjects with alcohol dependence or previously diagnosed with alcohol dependence
Subjects with other chronic liver disease (e.g., primary sclerosing cholangitis, alcoholic liver damage, hemochromatosis, Wilson's disease)
Presence, history, or family history of long QT syndrome or Torsades de Pointes
Subjects with heart failure (New York Heart Association Class III-IV)